Exact Mass: 352.11475720000004
Exact Mass Matches: 352.11475720000004
Found 145 metabolites which its exact mass value is equals to given mass value 352.11475720000004,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Penicilloic acid
C16H20N2O5S (352.10928700000005)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams Penicilloic acid is a metabolite of penicillin v; penicillin g.
Triflupromazine
Triflupromazine is only found in individuals that have used or taken this drug. It is a phenothiazine used as an antipsychotic agent and as an antiemetic. [PubChem]Triflupromazine binds to the dopamine D1 and dopamine D2 receptors and inhibits their activity. The mechanism of the anti-emetic effect is due predominantly to blockage of the dopamine D2 neurotransmitter receptors in the chemoreceptor trigger zone (CTZ) and vomiting centre. Triflupromazine blocks the neurotransmitter dopamine and the vagus nerve in the gastrointestinal tract. Triflupromazine also binds the muscarinic acetylcholine receptors (M1 and M2) and the tryptamine D receptors (5HT2B). N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AA - Phenothiazines with aliphatic side-chain D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent > C740 - Phenothiazine D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics
Roxadustat
B - Blood and blood forming organs > B03 - Antianemic preparations C471 - Enzyme Inhibitor Roxadustat is an orally active hypoxia-inducible factor (HIF) prolyl-hydroxylase (PHD) inhibitor (HIF-PHI) that promotes erythropoiesis through increasing endogenous erythropoietin, improving iron regulation, and reducing hepcidin[1].
FG-4592
B - Blood and blood forming organs > B03 - Antianemic preparations C471 - Enzyme Inhibitor Roxadustat is an orally active hypoxia-inducible factor (HIF) prolyl-hydroxylase (PHD) inhibitor (HIF-PHI) that promotes erythropoiesis through increasing endogenous erythropoietin, improving iron regulation, and reducing hepcidin[1].
O-beta-D-Glucopyranoside-2,3-Dihydro-5-hydroxy-2-methyl-1,4-naphthoquinone
5-(2S,1R)-hydroxy-2-(1,2-dihydroxy-4-oxo-cyclohexyl)-6,7-dimethoxy-2,3-dihydro-4H-chromen-4-one
methyl 4-(6,8-dihydroxy-3-methyl-1-oxoisochromen-7-yl)-2,4-dimethoxybutanoate
triflupromazine
N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AA - Phenothiazines with aliphatic side-chain D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent > C740 - Phenothiazine D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics
Benzylpenicilloic acid
C16H20N2O5S (352.10928700000005)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
methyl 4-(6,8-dihydroxy-3-methyl-1-oxoisochromen-7-yl)-2,4-dimethoxybutanoate [IIN-based: Match]
methyl 4-(6,8-dihydroxy-3-methyl-1-oxoisochromen-7-yl)-2,4-dimethoxybutanoate [IIN-based on: CCMSLIB00000848099]
Cys Gly Ser Ser
C11H20N4O7S (352.10526500000003)
Cys Ser Gly Ser
C11H20N4O7S (352.10526500000003)
Cys Ser Ser Gly
C11H20N4O7S (352.10526500000003)
Gly Cys Ser Ser
C11H20N4O7S (352.10526500000003)
Gly Ser Cys Ser
C11H20N4O7S (352.10526500000003)
Gly Ser Ser Cys
C11H20N4O7S (352.10526500000003)
Ser Cys Gly Ser
C11H20N4O7S (352.10526500000003)
Ser Cys Ser Gly
C11H20N4O7S (352.10526500000003)
Ser Gly Cys Ser
C11H20N4O7S (352.10526500000003)
Ser Gly Ser Cys
C11H20N4O7S (352.10526500000003)
Ser Ser Cys Gly
C11H20N4O7S (352.10526500000003)
Ser Ser Gly Cys
C11H20N4O7S (352.10526500000003)
2-Methylallyl triphenylphosphonium chloride
C22H22ClP (352.11475720000004)
Phosphonium,2-buten-1-yltriphenyl-, chloride (1:1)
C22H22ClP (352.11475720000004)
(s)-3-boc-amino-5-(carboxymethyl)-2,3-dihydro-1,5-benzothiazepin-4(5h)-one
C16H20N2O5S (352.10928700000005)
6-Chloro-1,2-dihydro-2-oxospiro[4H-3,1-benzoxazine-4,4-piperidine]-1-carboxylic acid tert-butyl ester
C17H21ClN2O4 (352.11897760000005)
1,2-Di-O-acetyl-5-Benzoyl-3-O-Methyl-D-ribofuranose
dimethyl 3,6-diphenyl-1,2,4,5-tetrazine-1,2-dicarboxylate
2-(1-Benzyl-4-hydroxy-2-oxo-1,2-dihydroquinoline-3-carboxamido)acetic acid
IOX2 is a specific prolyl hydroxylase-2 (PHD2) inhibitor with IC50 of 22 nM. IOX2 regulates platelet function and arterial thrombosis by upregulating HIF-1α expression and inhibiting ROS production. IOX2 can be used in the study of thrombotic diseases[1][2].
1-[[[1-(6-Methyl-2-pyridinyl)-4-imidazolyl]-oxomethyl]amino]-3-phenylthiourea
(5e)-14-Chloro-15,17-Dihydroxy-4,7,8,9,10,11-Hexahydro-2-Benzoxacyclopentadecine-1,12(3h,13h)-Dione
C18H21ClO5 (352.10774460000005)
(2S,5R,6R)-4-hydroxy-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4lambda4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
C16H20N2O5S (352.10928700000005)
Methyl 4-(6,8-dihydroxy-3-methyl-1-oxoisochromen-7-yl)-2,4-dimethoxybutanoate
2-[4-[3,4,5-Trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-2,3-dihydropyran-6-one
4-(3,4-dimethoxyphenyl)-3,4,5,6-tetrahydro-1H-benzo[h]quinazoline-2-thione
4-[(2,6-Diphenyl-4-pyrimidinyl)oxy]benzaldehyde
C23H16N2O2 (352.12117159999997)
1-[(2-Oxo-1,3-dihydroindol-5-yl)sulfonyl]-4-piperidinecarboxylic acid ethyl ester
C16H20N2O5S (352.10928700000005)
N-(2-furanylmethyl)-2-[4-(propylsulfamoyl)phenoxy]acetamide
C16H20N2O5S (352.10928700000005)
4-[[2-(Cyclohexylamino)-2-oxoethyl]thio]-3-nitrobenzoic acid methyl ester
C16H20N2O5S (352.10928700000005)
2-(3-acetyl-2-methyl-5-phenyl-1-pyrrolyl)-N-(thiophen-2-ylmethyl)acetamide
2-[[Cyclohexyl(oxo)methyl]amino]acetic acid [2-(2-chloroanilino)-2-oxoethyl] ester
C17H21ClN2O4 (352.11897760000005)
[(Z)-[phenyl(pyridin-2-yl)methylidene]amino] naphthalene-1-carboxylate
C23H16N2O2 (352.12117159999997)
2-Thiazolidineacetic acid, 4-carboxy-5,5-dimethyl-alpha-((phenylacetyl)amino)-
C16H20N2O5S (352.10928700000005)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
A-582941 (dihydrochloride)
A-582941 dihydrochloride is a potent, selective and brain-penetrant partial agonist of α7 nAChR, with Kis of 10.8 and 16.7 nM in rat brain membranes and human frontal cortex, respectively. A-582941 dihydrochloride also binds to human 5-HT3 receptor with a Ki of 150 nM. A-582941 has the potential for cognitive deficits associated with various neurodegenerative and psychiatric disorders research[1][2].
JNJ-46778212
C20H17FN2O3 (352.12231439999994)
JNJ-46778212 (VU 0409551) is an mGlu5 positive allosteric modulator with an EC50 of 260 nM.
Ro 10-5824 (dihydrochloride)
Ro 10-5824 dihydrochloride is a selective dopamine D4 receptor partial agonist, with Ki of 5.2 nM.
8-ethyl-2,7,10b-trihydroxy-4a,9-dimethoxy-1h,2h,5h-naphtho[2,1-b]pyran-3,6-dione
(6s)-6-(4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-5,6-dihydropyran-2-one
4-(5-hydroxy-7-methoxy-2-methyl-4-oxochromen-8-yl)-2,4-dimethoxybutanoic acid
13-chloro-14,16-dihydroxy-3-methyl-4,7,8,9,10,12-hexahydro-3h-2-benzoxacyclotetradecine-1,11-dione
C18H21ClO5 (352.10774460000005)
(2s,3r,4s,5s,6r)-2-[(4,8-dihydroxy-6-methylnaphthalen-1-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
12-imino-8,15,16-trimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,10,13,15-octaene-11,14-diol
methyl (2e,3z,5e)-6-(4-chloro-3-methoxyphenyl)-4-methoxy-2-(methoxymethylidene)-3-methylhexa-3,5-dienoate
C18H21ClO5 (352.10774460000005)
3-o-acetyl-2-o-(p-hydroxycinnamoyl)-α-l-rhamnose
{"Ingredient_id": "HBIN009023","Ingredient_name": "3-o-acetyl-2-o-(p-hydroxycinnamoyl)-\u03b1-l-rhamnose","Alias": "Ningposide C; 3-o-acetyl-2-o-(p-hydroxycinnamoyl)-alpha-l-rhamnose","Ingredient_formula": "C17H20O8","Ingredient_Smile": "CC1C(C(C(C(O1)O)OC(=O)C=CC2=CC=C(C=C2)O)OC(=O)C)O","Ingredient_weight": "352.3 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14146;SMIT19034","TCMID_id": "26094;415","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "10498169","DrugBank_id": "NA"}
6a,9-dihydroperoxy-9-methyl-3,6-dimethylidene-2-oxo-3ah,4h,5h,9ah,9bh-azuleno[4,5-b]furan-4-yl acetate
6-(4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-5,6-dihydropyran-2-one
(1s,2r,4s,5r,9s,10s,11r)-2-hydroperoxy-2,11-dimethyl-6-methylidene-7-oxo-8,12,13-trioxatetracyclo[9.2.2.0¹,¹⁰.0⁵,⁹]pentadec-14-en-4-yl acetate
16-hydroxy-4,5,15-trimethoxy-10-methyl-8-oxo-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,9(17),10,12,14-octaen-10-ium
(3ar,4s,6as,9r,9as,9bs)-6a,9-dihydroperoxy-6,9-dimethyl-3-methylidene-2-oxo-3ah,4h,9ah,9bh-azuleno[4,5-b]furan-4-yl acetate
2-[(4,8-dihydroxy-3-methylnaphthalen-1-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
6a,9-dihydroperoxy-6,9-dimethyl-3-methylidene-2-oxo-3ah,4h,9ah,9bh-azuleno[4,5-b]furan-4-yl acetate
methyl (1r,3r,4s,5r)-1,3,4-trihydroxy-5-{[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}cyclohexane-1-carboxylate
(3ar,4s,6as,9s,9as,9bs)-6a,9-dihydroperoxy-6,9-dimethyl-3-methylidene-2-oxo-3ah,4h,9ah,9bh-azuleno[4,5-b]furan-4-yl acetate
[(1s,3r,4r,5r)-1,3,4-trihydroxy-5-{[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}cyclohexyl]acetic acid
14-chloro-11,13-dihydroxy-4,5,9-trimethyl-4,5,6,7-tetrahydro-1h-3-benzoxacyclododecine-2,10-dione
C18H21ClO5 (352.10774460000005)
[5-(hydroxymethyl)-4-methoxy-6-(3-methoxy-3-oxoprop-1-en-1-yl)-2-oxopyran-3-yl]methyl 3-methylbut-2-enoate
(3s,4ar,10ar)-3-ethoxy-6,9,10a-trihydroxy-7-methoxy-3-methyl-1h,4h,4ah-naphtho[2,3-c]pyran-5,10-dione
methyl 1,3,5-trihydroxy-4-{[3-(4-hydroxyphenyl)prop-2-enoyl]oxy}cyclohexane-1-carboxylate
(1s,3r,4r,5r)-3-{[(3e)-4-(3,4-dihydroxyphenyl)buta-1,3-dien-2-yl]oxy}-1,4,5-trihydroxycyclohexane-1-carboxylic acid
3-{[4-(3,4-dihydroxyphenyl)buta-1,3-dien-2-yl]oxy}-1,4,5-trihydroxycyclohexane-1-carboxylic acid
(2r,4as,10br)-8-ethyl-2,7,10b-trihydroxy-4a,9-dimethoxy-1h,2h,5h-naphtho[2,1-b]pyran-3,6-dione
(3ar,4s,6as,9r,9as,9bs)-6a,9-dihydroperoxy-9-methyl-3,6-dimethylidene-2-oxo-3ah,4h,5h,9ah,9bh-azuleno[4,5-b]furan-4-yl acetate
methyl 6-(4-chloro-3-methoxyphenyl)-4-methoxy-2-(methoxymethylidene)-3-methylhexa-3,5-dienoate
C18H21ClO5 (352.10774460000005)
(3r,5e)-13-chloro-14,16-dihydroxy-3-methyl-4,7,8,9,10,12-hexahydro-3h-2-benzoxacyclotetradecine-1,11-dione
C18H21ClO5 (352.10774460000005)
(6s)-6-(4-{[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-5,6-dihydropyran-2-one
methyl (3e)-6-(4-chloro-3-methoxyphenyl)-4-methoxy-2-(methoxymethylidene)-3-methylhexa-3,5-dienoate
C18H21ClO5 (352.10774460000005)
5-(acetyloxy)-2,4-dihydroxy-6-methyloxan-3-yl 3-(4-hydroxyphenyl)prop-2-enoate
methyl 1,3,4-trihydroxy-5-{[3-(4-hydroxyphenyl)prop-2-enoyl]oxy}cyclohexane-1-carboxylate
(2r,4r)-4-(5-hydroxy-7-methoxy-2-methyl-4-oxochromen-8-yl)-2,4-dimethoxybutanoic acid
(2s)-2-methyl-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3-dihydronaphthalene-1,4-dione
(2r,3r,4r,5s,6s)-4-(acetyloxy)-2,5-dihydroxy-6-methyloxan-3-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate
(1s,2s,4s,5r,9s,10s,11r)-2-hydroperoxy-2,11-dimethyl-6-methylidene-7-oxo-8,12,13-trioxatetracyclo[9.2.2.0¹,¹⁰.0⁵,⁹]pentadec-14-en-4-yl acetate
methyl (1r,3r,4r,5r)-1,3,5-trihydroxy-4-{[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}cyclohexane-1-carboxylate
methyl (1s,3r,4s,5r)-1,3,5-trihydroxy-4-{[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}cyclohexane-1-carboxylate
(1r,3s,4s,5r)-3-[4-(3,4-dihydroxyphenyl)-2-oxobut-3-en-1-yl]-1,4,5-trihydroxycyclohexane-1-carboxylic acid
(2r,4s)-4-(5-hydroxy-7-methoxy-2-methyl-4-oxochromen-8-yl)-2,4-dimethoxybutanoic acid
(8e)-14-chloro-11,13-dihydroxy-4,5,9-trimethyl-4,5,6,7-tetrahydro-1h-3-benzoxacyclododecine-2,10-dione
C18H21ClO5 (352.10774460000005)
4-[4-methyl-5-(3-oxo-3-phenylprop-1-yn-1-yl)-2-phenylfuran-3-yl]but-3-yn-2-one
(1,3,4-trihydroxy-5-{[3-(4-hydroxyphenyl)prop-2-enoyl]oxy}cyclohexyl)acetic acid
3-ethoxy-6,9,10a-trihydroxy-7-methoxy-3-methyl-1h,4h,4ah-naphtho[2,3-c]pyran-5,10-dione
(1r,3s,4s,5r)-3-[(3e)-4-(3,4-dihydroxyphenyl)-2-oxobut-3-en-1-yl]-1,4,5-trihydroxycyclohexane-1-carboxylic acid
2-hydroperoxy-2,11-dimethyl-6-methylidene-7-oxo-8,12,13-trioxatetracyclo[9.2.2.0¹,¹⁰.0⁵,⁹]pentadec-14-en-4-yl acetate
[5-(hydroxymethyl)-4-methoxy-6-[(1e)-3-methoxy-3-oxoprop-1-en-1-yl]-2-oxopyran-3-yl]methyl 3-methylbut-2-enoate
(5z)-13-chloro-14,16-dihydroxy-3-methyl-4,7,8,9,10,12-hexahydro-3h-2-benzoxacyclotetradecine-1,11-dione
C18H21ClO5 (352.10774460000005)